Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Nov;84(22):8095–8099. doi: 10.1073/pnas.84.22.8095

Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.

O Ploux 1, S Lavielle 1, G Chassaing 1, S Julien 1, A Marquet 1, P d'Orléans-Juste 1, S Dion 1, D Regoli 1, J C Beaujouan 1, L Bergström 1, et al.
PMCID: PMC299485  PMID: 2446317

Abstract

The activities of two groups of cyclic agonists of substance P (SP) have been studied. The disulfide bridge constraints have been designed on the basis of conformational studies on SP and physalaemin indicating an alpha-helical structure for the core of these two tachykinins (group I) and a folding of the C-terminal carboxamide towards the side chains of the glutamines 5 and 6 (group II). Only peptides simulating the alpha-helix present substantial potencies. [Cys3,6]SP is as active as SP in inhibiting 125I-labeled Bolton and Hunter SP-specific binding on rat brain synaptosomes and on dog carotid bioassay, two assays specific for the neurokinin 1 receptor. Moreover, [Cys3,6]SP is as potent as neurokinin B in inhibiting 125I-labeled Bolton and Hunter eledoisin-specific binding on rat cortical synaptosomes as well as in stimulating rat portal vein, two tests specific for the neurokinin 3 receptor. Interestingly, in contrast to neurokinin B, [Cys3,6]SP is a weak agonist of the neurokinin 2 receptor subtype, as evidenced by its binding potency in inhibiting 3H-labeled neurokinin A-specific binding on rat duodenum and in inducing the contractions of the rabbit pulmonary artery, a neurokinin 2-type bioassay. To increase the specificity of the cyclic analogue [Cys3,6]SP positions 8 and 9 were modified. [Cys3,6, Tyr8, Ala9]SP is slightly less selective than SP for the neurokinin 1 receptor subtype. [Cys2,5]neurokinin B constitutes a selective cyclic agonist for the neurokinin 3 receptor. The very weak potencies of the peptides from group II indicate that a certain degree of flexibility in the C-terminal moiety is required. Collectively, these results suggest that the neurokinin 1 and neurokinin 3 tachykinin receptors may recognize a similar three-dimensional structure of the core of the tachykinins. Different orientations of the common C-terminal tripeptide may be related to the selectivity for the different receptor subtypes.

Full text

PDF
8095

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaujouan J. C., Torrens Y., Herbet A., Daguet M. C., Glowinski J., Prochiantz A. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture. Mol Pharmacol. 1982 Jul;22(1):48–55. [PubMed] [Google Scholar]
  2. Beaujouan J. C., Torrens Y., Viger A., Glowinski J. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol. 1984 Sep;26(2):248–254. [PubMed] [Google Scholar]
  3. Buck S. H., Burcher E., Shults C. W., Lovenberg W., O'Donohue T. L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science. 1984 Nov 23;226(4677):987–989. doi: 10.1126/science.6095447. [DOI] [PubMed] [Google Scholar]
  4. Buck S. H., Maurin Y., Burks T. F., Yamamura H. I. High-affinity 3H-substance P binding to longitudinal muscle membranes of the guinea pig small intestine. Life Sci. 1984 Jan 30;34(5):497–507. doi: 10.1016/0024-3205(84)90506-x. [DOI] [PubMed] [Google Scholar]
  5. Burcher E., Buck S. H., Lovenberg W., O'Donohue T. L. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacol Exp Ther. 1986 Mar;236(3):819–831. [PubMed] [Google Scholar]
  6. Cascieri M. A., Liang T. Characterization of the substance P receptor in rat brain cortex membranes and the inhibition of radioligand binding by guanine nucleotides. J Biol Chem. 1983 Apr 25;258(8):5158–5164. [PubMed] [Google Scholar]
  7. Chassaing G., Convert O., Lavielle S. Conformational analogy between substance P and physalaemin. Biochim Biophys Acta. 1986 Oct 17;873(3):397–404. doi: 10.1016/0167-4838(86)90089-0. [DOI] [PubMed] [Google Scholar]
  8. Chassaing G., Convert O., Lavielle S. Preferential conformation of substance P in solution. Eur J Biochem. 1986 Jan 2;154(1):77–85. doi: 10.1111/j.1432-1033.1986.tb09361.x. [DOI] [PubMed] [Google Scholar]
  9. Cotrait M., Hospital M. Conformational studies on substance P. C-terminal pentapeptide pGlu-Phe-Phe-Gly-Leu-Met NH2. Biochem Biophys Res Commun. 1982 Dec 31;109(4):1123–1128. doi: 10.1016/0006-291x(82)91893-9. [DOI] [PubMed] [Google Scholar]
  10. D'Orléans-Juste P., Dion S., Drapeau G., Regoli D. Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol. 1986 Jun 5;125(1):37–44. doi: 10.1016/0014-2999(86)90081-6. [DOI] [PubMed] [Google Scholar]
  11. Darman P. S., Landis G. C., Smits J. R., Hirning L. D., Gulya K., Yamamura H. I., Burks T. F., Hruby V. J. Conformationally restricted cyclic analogues of substance P: insight into the receptor binding process. Biochem Biophys Res Commun. 1985 Mar 15;127(2):656–662. doi: 10.1016/s0006-291x(85)80211-4. [DOI] [PubMed] [Google Scholar]
  12. Dion S., Drapeau G., Rhaleb N. E., D'Orléans-Juste P., Regoli D. Receptors for substance P and neurokinins. Correlation between binding and biological activities. Eur J Pharmacol. 1987 Jun 12;138(1):125–128. doi: 10.1016/0014-2999(87)90347-5. [DOI] [PubMed] [Google Scholar]
  13. Hruby V. J. Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci. 1982 Jul 19;31(3):189–199. doi: 10.1016/0024-3205(82)90578-1. [DOI] [PubMed] [Google Scholar]
  14. Hruby V. J., Mosberg H. I., Sawyer T. K., Knittel J. J., Rockway T. W., Ormberg J., Darman P., Chan W. Y., Hadley M. E. Conformational and dynamic considerations in the design of peptide hormone analogs. Biopolymers. 1983 Jan;22(1):517–530. doi: 10.1002/bip.360220165. [DOI] [PubMed] [Google Scholar]
  15. Kaiser E., Colescott R. L., Bossinger C. D., Cook P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 1970 Apr;34(2):595–598. doi: 10.1016/0003-2697(70)90146-6. [DOI] [PubMed] [Google Scholar]
  16. König W., Geiger R. Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexycarbodiimid unter Zusatz von 1-Hydroxy-benzotriazolen. Chem Ber. 1970;103(3):788–798. doi: 10.1002/cber.19701030319. [DOI] [PubMed] [Google Scholar]
  17. Laufer R., Gilon C., Chorev M., Selinger Z. Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand. J Biol Chem. 1986 Aug 5;261(22):10257–10263. [PubMed] [Google Scholar]
  18. Lavielle S., Chassaing G., Besseyre J., Marquet A., Bergström L., Beaujouan J. C., Torrens Y., Glowinski J. A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes. Eur J Pharmacol. 1986 Sep 9;128(3):283–285. doi: 10.1016/0014-2999(86)90779-x. [DOI] [PubMed] [Google Scholar]
  19. Lavielle S., Chassaing G., Julien S., Besseyre J., Marquet A. Influence of the amino acids of substance P in the recognition of its receptor: affinities of synthesized SP analogues for the specific 125I-BHSP binding site on rat brain synaptosomes. Neuropeptides. 1986 Feb-Mar;7(2):191–200. doi: 10.1016/0143-4179(86)90094-6. [DOI] [PubMed] [Google Scholar]
  20. Lavielle S., Chassaing G., Julien S., Marquet A., Bergström L., Beaujouan J. C., Torrens Y., Glowinski J. Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. Eur J Pharmacol. 1986 Jun 24;125(3):461–462. doi: 10.1016/0014-2999(86)90804-6. [DOI] [PubMed] [Google Scholar]
  21. Manavalan P., Momany F. A. Conformational energy calculations on substance P. Int J Pept Protein Res. 1982 Oct;20(4):351–365. doi: 10.1111/j.1399-3011.1982.tb00900.x. [DOI] [PubMed] [Google Scholar]
  22. Mehlis B., Rueger M., Becker M., Bienert M., Niedrich H., Oehme P. Circular dichroism studies of substance P and its C-terminal sequences. CD spectra in aqueous solution and effects of hydrogen ion concentration. Int J Pept Protein Res. 1980 Jan;15(1):20–28. [PubMed] [Google Scholar]
  23. Mizrahi J., Dion S., D'Orléans-Juste P., Escher E., Drapeau G., Regoli D. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Eur J Pharmacol. 1985 Nov 26;118(1-2):25–36. doi: 10.1016/0014-2999(85)90659-4. [DOI] [PubMed] [Google Scholar]
  24. Neubert K., Mansfeld H. W., Jakubke H. D., Bergmann J. Uber die Darstellung modifizierter Tachykinin-Teilsequenzen. Pharmazie. 1979 May-Jun;34(5-6):347–349. [PubMed] [Google Scholar]
  25. Ninkovic M., Beaujouan J. C., Torrens Y., Saffroy M., Hall M. D., Glowinski J. Differential localization of tachykinin receptors in rat spinal cord. Eur J Pharmacol. 1984 Nov 13;106(2):463–464. doi: 10.1016/0014-2999(84)90744-1. [DOI] [PubMed] [Google Scholar]
  26. Ploux O., Chassaing G., Marquet A. Cyclization of peptides on a solid support. Application to cyclic analogs of substance P. Int J Pept Protein Res. 1987 Feb;29(2):162–169. doi: 10.1111/j.1399-3011.1987.tb02242.x. [DOI] [PubMed] [Google Scholar]
  27. Quirion R., Shults C. W., Moody T. W., Pert C. B., Chase T. N., O'Donohue T. L. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 1983 Jun 23;303(5919):714–716. doi: 10.1038/303714a0. [DOI] [PubMed] [Google Scholar]
  28. Regoli D., D'Orléans-Juste P., Escher E., Mizrahi J. Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol. 1984 Jan 27;97(3-4):161–170. doi: 10.1016/0014-2999(84)90447-3. [DOI] [PubMed] [Google Scholar]
  29. Regoli D., Drapeau G., Dion S., D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci. 1987 Jan 12;40(2):109–117. doi: 10.1016/0024-3205(87)90349-3. [DOI] [PubMed] [Google Scholar]
  30. Rueger M., Bienert M., Mehlis B., Gast K., Zirwer D., Behlke J. Self-association of the neuroregulatory peptide substance P and Its C-terminal sequences. Biopolymers. 1984 Apr;23(4):747–758. doi: 10.1002/bip.360230413. [DOI] [PubMed] [Google Scholar]
  31. Theodoropoulos D., Poulos C., Gatos D., Cordopatis P., Escher E., Mizrahi J., Regoli D., Dalietos D., Furst A., Lee T. D. Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties. J Med Chem. 1985 Oct;28(10):1536–1539. doi: 10.1021/jm00148a029. [DOI] [PubMed] [Google Scholar]
  32. Torrens Y., Lavielle S., Chassaing G., Marquet A., Glowinski J., Beaujouan J. C. Neuromedin K, a tool to further distinguish two central tachykinin binding sites. Eur J Pharmacol. 1984 Jul 13;102(2):381–382. doi: 10.1016/0014-2999(84)90276-0. [DOI] [PubMed] [Google Scholar]
  33. Viger A., Beaujouan J. C., Torrens Y., Glowinski J. Specific binding of a 125I-substance P derivative to rat brain synaptosomes. J Neurochem. 1983 Apr;40(4):1030–1039. doi: 10.1111/j.1471-4159.1983.tb08089.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES